Aamir Malik

Executive VP & Chief U.S. Commercial Officer, Pfizer

Search every verified Aamir Malik interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Aamir Malik, Executive Vice President and Chief Business Innovation Officer at Pfizer, spoke at The Atlantic Festival 2023 and the CNBC Work Summit in 2023. At The Atlantic Festival, Malik discussed Pfizer's focus on antibody drug conjugates (ADCs) as a technology for cancer treatment, describing them as "guided missiles" that seek out and destroy cancer cells. He stated that Pfizer was proposing the acquisition of Seagen, which he called the world leader in ADCs, and said the company had deployed "the largest amount of resource in its recent history" to advance cancer research. Malik also highlighted Pfizer's "Accord for a Healthier World" initiative, under which the company committed to delivering all its current and future medicines and vaccines on a non-profit basis to 1.2 billion people in the 45 poorest countries. At the CNBC Work Summit, Malik discussed Pfizer's response to the COVID-19 pandemic, emphasizing the role of the company's purpose—"breakthroughs that change patients' lives"—as a guiding principle. He described how manufacturing colleagues were called "heroes" for showing up daily to produce medicines, while research staff worked to find a cure. Malik also spoke about Pfizer's approach to innovation, including efforts to reduce bias in decision-making and to tap into external scientific developments, noting that this strategy helped bring solutions during the pandemic. He mentioned that Pfizer aimed to shorten drug development timelines, stating that taking three years out of the process could accelerate bringing medicines to patients.